Health Technology Assessment

A health technology assessment of robot-assisted keyhole surgery has concluded that while the benefits to patients in certain surgical procedures are evident, the cost of its introduction would be significant.

HTA-robot-assisted-surgery.pdf

These Guidelines set out to evaluate the clinical effectiveness of health technologies for the Irish health service. They provide direction on how to measure the ability of a healthcare technology to make a significant difference to a patient’s health status.

HTA-Clinical-Effectiveness-Guidelines.pdf

The purpose of these guidelines is to assist those conducting or using HTA in Ireland. They also inform health technology suppliers who prepare applications for reimbursement. These draft guidelines are now available for consultation.

Draft-HTA-Clinical-Effectiveness-Guidelines.pdf

This health technology assessment (HTA) examined the potential for a new technology, prion filtration, to reduce the risk of variant Creutzfeldt-Jakob disease (vCJD) transmission from the transfusion of red cell concentrates (RCC) in Ireland.

HTA-Prion-Filtration.pdf

Colorectal cancer is the second most frequently diagnosed cancer in men and women in this country. During the time period 2002 to 2005, an average of 2,040 new cases of colorectal cancer were diagnosed each year. During the same time period, an average of 925 people died each year from the disease.

In June 2009, the Minister for Health and Children requested the Authority to:

Colorectal_cancer_evaluation_report_HTA.pdf

This document, Guidelines for Budget Impact Analysis of Health Technologies in Ireland is a complementary document to the Guidelines for Economic Evaluation of Health Technologies in Ireland (2010). They are limited to methodological guidance on the conduct of budget impact analysis and are intended to promote best practice in budget impact analysis (BIA). They will be reviewed and revised as necessary. The purpose of these BIA guidelines is to assist those conducting or using BIA as part of HTA in Ireland.

HTA_Guidelines_for_Budget_Impact_Analysis.pdf

In July 2007, the Health Information and Quality Authority agreed to carry out a health technology assessment (HTA) on the role of vaccination against human papillomavirus (HPV) in reducing the risk of cervical cancer in Ireland in response to a request by the National Cancer Screening Service Board.

HTA_HPV_Full_report.pdf

In July 2002, the Clinical Indemnity Scheme (CIS) was established to rationalise the current medical indemnity arrangements by transferring to the State, via health boards (now the HSE), hospitals and other health agencies, responsibility for managing clinical negligence claims and associated risks. Under the scheme, which is managed by the State Claims Agency (SCA), the State assumed full responsibility for the indemnification and management of all clinical negligence claims. A key feature of the CIS is electronic incident reporting.

HIQA_STARSweb_Report_2008_07_10.pdf

HIQA_STARSweb_Executive_Summary_2008_07_10.pdf

In July 2007, the Health Information and Quality Authority agreed to carry out a health technology assessment (HTA) on the role of vaccination against human papillomavirus (HPV) in reducing the risk of cervical cancer in Ireland in response to a request by the National Cancer Screening Service Board.

HTA_HPV_Full_report.pdf